Clinical activity and tolerability of enzalutamide (MDV3100) in patients with metastatic, castration-resistant prostate cancer who progress after docetaxel and abiraterone treatment

Author： Badrising Sushil   van der Noort Vincent   van Oort Inge M.   van den Berg H. Pieter   Los Maartje   Hamberg Paul   Coenen Jules L.   van den Eertwegh Alfons J. M.   de Jong Igle J.   Kerver Emile D.   van Tinteren Harm   Bergman Andries M.  

Publisher： Blackwell Publishing

E-ISSN： 1097-0142|120|7|968-975

ISSN： 0008-543X

Source： Cancer, Vol.120, Iss.7, 2014-04, pp. : 968-975

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Abiraterone Acetate: In Metastatic Castration-Resistant Prostate Cancer

By Yang Lily P.H.  

Drugs, Vol. 71, Iss. 15, 2011-10 ,pp. : 2067-2077

Adis International

Access to resources Recommend Favorite

Abiraterone Acetate: A Guide to Its Use in Metastatic Castration-Resistant Prostate Cancer

By Scott Lesley J.   Yang Lily P.H.   Lyseng-Williamson Katherine A.  

Drugs & Aging, Vol. 29, Iss. 3, 2012-03 ,pp. : 243-248

Adis International

Access to resources Recommend Favorite

MDV3100 for the treatment of prostate cancer

By Mukherji Deborah   Pezaro Carmel J   De-Bono Johann S  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 2, 2012-02 ,pp. : 227-233

Informa Healthcare

Access to resources Recommend Favorite

Sipuleucel-T: In Metastatic Castration-Resistant Prostate Cancer

By Plosker Greg L.  

Drugs, Vol. 71, Iss. 1, 2011-01 ,pp. : 101-108

Adis International

Access to resources Recommend Favorite

Abiraterone acetate for castration resistant prostate cancer

By Shah Shreya   Ryan Charles  

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 4, 2010-04 ,pp. : 563-570

Informa Healthcare

Access to resources Recommend Favorite